Seraph 100
- Seraph 100
- Our technology
COVID-19 & Seraph
- COVID-19 & Seraph
- Clinical Trials
About ExThera Medical
News
Events
International (English)
Contact

Seraph 100
- Seraph 100
- Our technology
COVID-19 & Seraph
- COVID-19 & Seraph
- Clinical Trials
About ExThera Medical
News
Events
International (English)
Contact

menu

Absorption of Circulating Tumor Cells by Hemoperfusion

Absorption of Circulating Tumor Cells by Hemoperfusion

Download the full article here

Stay up to date

Join our newsletter by filling in the fields below

Name*
Email address*

Contact

ExThera Medical Corporation

757 Arnold Drive, Suite B
Martinez, California 94553

Tel: +1.925.839.2060
Fax: +1.925.839.2075

Navigation

Seraph 100
- Seraph 100
- Our technology
COVID-19 & Seraph
- COVID-19 & Seraph
- Clinical Trials
About ExThera Medical
News
Events
International (English)
Contact

Partners / Certifications

Socials

News

ExThera Medical & Fresenius Medical Care Sign Distri...
Patient Enrollment is Complete in the DOD-Funded Study of...
Treatment for critically ill COVID patients results in si...
ExThera Medical and Asahi Kasei Medical Enter into Partne...
How to save a life: Local firefighter with COVID-19 gets ...

© 2024 ExThera Medical | Webdevelopment by webmix

The Seraph 100 Microbind Affinity Blood Filter (Seraph 100) is CE Marked and approved for commercial sale in Europe. | Privacy policy